IP Library › Patent Application 15942440
Patent Application
App. No. 15/942,440

GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/942,440
Abstract

The present invention relates to a pharmaceutical composition for the prevention or treatment of diabetic neuropathy, wherein the pharmaceutical composition comprises, as active ingredients, different types of isoforms of HGF or a polynucleotide encoding the isoforms. The present invention is the first invention demonstrating that diabetic neuropathy can be prevented and treated using different types of isoforms of HGF. According to the present invention, it is possible to very effectively treat diabetic neuropathy.

Claims (1)

1 . A pharmaceutical composition for the prevention or treatment of diabetic neuropathy, the composition comprising, as active ingredients, different types of isoforms of hepatocyte growth factor (HGF) or at least one polynucleotide encoding the isoforms.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME FROM --HELIXMITH CO., LTD PREVIOUSLY RECORDED AT REEL: 049151 FRAME: 0562. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 24, 2020
From: VIROMED CO., LTD
To: HELIXMITH CO., LTD
Reel/Frame 054511/0459 →
CHANGE OF NAME Recorded May 10, 2019
From: VIROMED CO., LTD.
To: HELIXMITH CO., LTD
Reel/Frame 049151/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: KIM, JONG MOOK; JEONG, JAE GYUN
To: VIROMED CO., LTD.
Reel/Frame 045849/0181 →